| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/31/2004 | EP1403376A2 Expression of heterologous genes according to a targeted expression profile |
| 03/31/2004 | EP1403375A2 Recombinant live avian vaccin, using avian herpes virus as vector |
| 03/31/2004 | EP1403372A2 Composition and methods for the treatment and diagnosis of cardiovascular disease |
| 03/31/2004 | EP1403371A1 Novel polypeptide and use thereof |
| 03/31/2004 | EP1403370A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria |
| 03/31/2004 | EP1403368A1 Testicular carnitine transporter and its gene |
| 03/31/2004 | EP1403367A1 Method of testing drug for treating or preventing diseases such as hyperlipemia |
| 03/31/2004 | EP1403365A1 Polypeptide unstabilizing protein in cells under aerobic conditions and dna encoding the same |
| 03/31/2004 | EP1403285A1 Fibroblast growth factor receptors |
| 03/31/2004 | EP1403284A1 HAb18G/CD147, IT'S AGONIST AND APPLICATION |
| 03/31/2004 | EP1403283A1 Tumor antigen |
| 03/31/2004 | EP1403282A1 Protein complexes of the Tumor necrosis factor-alpha (TNF-alpha) signalling pathway |
| 03/31/2004 | EP1403281A1 Novel ligand and dna thereof |
| 03/31/2004 | EP1403280A1 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7 |
| 03/31/2004 | EP1403279A1 Protein polymer having unfold activity on higher-order structure of protein |
| 03/31/2004 | EP1402903A1 Method of transporting physiological polymer using protein having rxp repeated sequence |
| 03/31/2004 | EP1402897A2 Novel indications of Mannan-binding lectin (MBL) in the treatment of immunocompromised individuals |
| 03/31/2004 | EP1402451A1 Solution structure of il-13 and uses thereof |
| 03/31/2004 | EP1402341A1 Essential and important genes of pseudomonas aeruginosa and the use thereof to design or identify antibacterial agents |
| 03/31/2004 | EP1402271A2 Benzophenone-linked crf and crf-like peptides for covalent labeling of corticotropin-releasing factor (crf) binding protein |
| 03/31/2004 | EP1402261A1 Colon cancer antigen panel |
| 03/31/2004 | EP1402260A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 03/31/2004 | EP1402256A2 P-cadherin as a target for anti-cancer therapy |
| 03/31/2004 | EP1402075A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 03/31/2004 | EP1402058A2 Dgks as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1402054A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 03/31/2004 | EP1402053A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 03/31/2004 | EP1402050A2 Methods for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gp41 fragments |
| 03/31/2004 | EP1402049A2 Production of high levels of transgenic factor viii with engineered stability, and its therapeutic uses |
| 03/31/2004 | EP1402042A2 Abiotic stress responsive polynucleotides and polypeptides |
| 03/31/2004 | EP1402040A2 A novel intein and uses thereof |
| 03/31/2004 | EP1402039A1 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS |
| 03/31/2004 | EP1402038A2 Identification and characterization of plant genes |
| 03/31/2004 | EP1402037A1 Plant genes involved in defense against pathogens |
| 03/31/2004 | EP1402035A2 G-protein coupled receptors and dna sequences thereof |
| 03/31/2004 | EP1402034A2 Identification of ses-1 and the uses of the same |
| 03/31/2004 | EP1402033A2 Novel endothelially expressed dnas and proteins, and their use |
| 03/31/2004 | EP1402032A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis |
| 03/31/2004 | EP1402031A2 Atopy |
| 03/31/2004 | EP1402030A2 43238, a g protein-coupled receptor and uses therefor |
| 03/31/2004 | EP1402029A2 Use of inhibitors of expression or activity of p8/com1 for treating tumors |
| 03/31/2004 | EP1402025A1 Chimaeric phages |
| 03/31/2004 | EP1402021A1 A gene and uses therefor |
| 03/31/2004 | EP1402019A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 03/31/2004 | EP1402015A2 A soluble complex comprising a retroviral surface glycoprotein |
| 03/31/2004 | EP1402000A2 Structural and cytoskeleton-associated proteins |
| 03/31/2004 | EP1401999A2 B7 related protein-2 molecules and uses thereof |
| 03/31/2004 | EP1401869A1 Molecules and methods for inhibiting shedding of kim-1 |
| 03/31/2004 | EP1401868A2 Ion channel modulators |
| 03/31/2004 | EP1401867A2 Mycobacterial antigens expressed under low oxygen tension |
| 03/31/2004 | EP1401866A2 Comparative mycobacterial genomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses |
| 03/31/2004 | EP1401865A2 Pathogenic and commensal vaccine antigens |
| 03/31/2004 | EP1401863A1 Somatostatin-dopamine chimeric analogs |
| 03/31/2004 | EP1401858A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/31/2004 | EP1401857A2 Purification of human serum albumin |
| 03/31/2004 | EP1401855A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 03/31/2004 | EP1401504A1 Uv-screening peptide-flavonoid conjugates |
| 03/31/2004 | EP1401494A1 Tumor therapy |
| 03/31/2004 | EP1401493A1 Subunit vaccines and processes for the production thereof |
| 03/31/2004 | EP1401490A1 Tsg101 as inhibitor of hiv production |
| 03/31/2004 | EP1401486A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 03/31/2004 | EP1401480A2 Use of endostatin in the treatment of ocular neovascularization |
| 03/31/2004 | EP1401478A2 Antimicrobial peptides |
| 03/31/2004 | EP1401477A2 Chemokine beta-1 fusion proteins |
| 03/31/2004 | EP1401476A2 Igf antagonist peptides |
| 03/31/2004 | EP1401475A2 Prmts as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1401473A2 Transporters comprising spaced arginine moieties |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401470A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 03/31/2004 | EP1401467A1 Alpha-fetoprotein peptides and uses thereof |
| 03/31/2004 | EP1401412A2 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis |
| 03/31/2004 | EP1401411A2 Use of tyrosine kinase inhibitors for treating bone loss |
| 03/31/2004 | EP1401410A2 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 03/31/2004 | EP1401377A2 Methods for treating cancer |
| 03/31/2004 | EP1401376A2 Colloidal metal compositions and methods |
| 03/31/2004 | EP1401286A1 Method of inhibiting fungal growth |
| 03/31/2004 | EP1401281A2 Toll/interleukin-1 receptor adaptor protein (tirap) |
| 03/31/2004 | EP1401269A2 Transgenic animal model of bone mass modulation |
| 03/31/2004 | EP1401267A1 Animal model for allergy |
| 03/31/2004 | EP1366059A4 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 03/31/2004 | EP1232174A4 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 03/31/2004 | EP1210102A4 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 03/31/2004 | EP1158850A4 Plants and feed baits for controlling damage from feeding insects |
| 03/31/2004 | EP1035871B1 Oxidative method for attachment of glycoproteins or glycopeptides to surfaces of medical devices |
| 03/31/2004 | EP1019507B1 Amino-terminally truncated rantes as chemokine antagonists |
| 03/31/2004 | EP1015560B1 Modified small rna viruses |
| 03/31/2004 | EP1012256B1 Recombinant fusion proteins based on ribosome-inactivating proteins of european mistletoe viscum album |
| 03/31/2004 | EP1003863B1 Mammalian cytokine receptor-11 |
| 03/31/2004 | EP0973887B1 Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| 03/31/2004 | EP0935652B1 Keratinocyte growth factor-2 products |
| 03/31/2004 | EP0866860B1 Novel tyrosine kinase receptors and ligands |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/31/2004 | EP0746625B1 Targetable vector particles |
| 03/31/2004 | EP0735818B1 MACROPHAGE INFLAMMATORY PROTEINS MIP-3, MIP-4 AND MIP-1gamma |
| 03/31/2004 | EP0731806B1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
| 03/31/2004 | EP0710253B1 Antibodies specific for human prostate glandular kallikrein |
| 03/31/2004 | EP0681477B1 Genetic modification of neural stem cells |
| 03/31/2004 | EP0666916B1 Plasmodium falciparum antigens inducing protective antibodies |
| 03/31/2004 | EP0656948B1 Bordetella bronchiseptica vaccine |
| 03/31/2004 | CN1486369A Method for separating and identifying flower pesticide specific promoter of cotton |